Emcure Pharmaceuticals’ IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories allocated for Non-Institutional Investors (NII) and retail investors saw the highest demand, with subscriptions reaching 7.5 times and 2.6 times, respectively.
| Subscribe To Our Free Newsletter |
